Vertex Pharmaceuticals Inc. buy Scotiabank
Start price
14.11.25
/
50%
€377.95
Target price
14.11.26
-
Performance (%)
3.64%
Price
30.12.25
€391.70
Summary
This prediction is currently active. The BUY prediction by Scotiabank shows slight gains of 3.64%. This prediction currently runs until 14.11.26. The prediction end date can be changed by Scotiabank at any time. Scotiabank has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | 0.591% | 0.591% |
| iShares Core DAX® | 0.794% | 2.841% |
| iShares Nasdaq 100 | 0.016% | -0.939% |
| iShares Nikkei 225® | 0.309% | -0.648% |
| iShares S&P 500 | 0.181% | -0.442% |
Comments by Scotiabank for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Scotiabank to a "strong-buy" rating.
Ratings data for VRTX provided by MarketBeat